Top Buy
Security | Buy | Sell ▲ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Innoviva Inc. | 3 | 0 | 0 | 0 | €14.20 | €30.00 | 111.268% |
Akero Therapeutics Inc | 14 | 0 | 2 | 0 | €16.90 | €38.19 | 125.998% |
Twist Bioscience Corp | 7 | 0 | 3 | 0 | €37.73 | €41.41 | 9.751% |
Cocrystal Pharma Inc. | 7 | 0 | 1 | 0 | €1.94 | €9.25 | 377.010% |
Blueprint Medicines Corp | 2 | 0 | 1 | 0 | €98.16 | - | - |
Vericel Corp. | 1 | 0 | 0 | 0 | €43.20 | - | - |
Vanda Pharmaceuticals | 4 | 0 | 0 | 0 | €4.64 | €5.00 | 7.759% |
Amgen Inc. | 25 | 0 | 4 | 0 | €277.95 | €296.16 | 6.550% |
Deciphera Pharmaceuticals | 6 | 0 | 0 | 0 | €23.20 | €21.66 | -6.642% |
Xencor Inc. | 10 | 1 | 1 | 0 | €21.20 | €32.58 | 53.674% |
Regeneron Pharmaceuticals Inc. | 36 | 1 | 3 | 0 | €896.00 | €958.32 | 6.955% |
G1 Therapeutics | 20 | 1 | 7 | 0 | €3.06 | €10.05 | 228.562% |
Nektar Therapeutics | 3 | 1 | 0 | 0 | €1.17 | €3.70 | 216.781% |
Heron Therapeutics Inc. | 11 | 1 | 3 | 0 | €3.18 | €4.59 | 44.217% |
Amneal Pharmaceuticals Inc | 1 | 1 | 0 | 0 | €6.25 | €10.00 | 60.000% |
Merck & Co. Inc. | 28 | 1 | 0 | 0 | €115.00 | €124.92 | 8.628% |
Celldex Therapeutics | 11 | 1 | 2 | 0 | €32.60 | €56.62 | 73.672% |
Natural Alternat. | 19 | 1 | 2 | 0 | €5.95 | - | - |
Corvus Pharmaceuticals Inc | 5 | 1 | 1 | 0 | €1.80 | €6.45 | 259.276% |
Cara Therapeutics Inc. | 11 | 1 | 3 | 0 | €0.55 | €4.62 | 734.869% |
Biogen Inc. | 50 | 1 | 7 | 0 | €203.30 | €293.22 | 44.232% |
Ultragenyx Pharmaceutical Inc. | 17 | 1 | 1 | 0 | €35.40 | €84.74 | 139.390% |
Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 0 | 0 | €39.20 | €50.00 | 27.551% |
Chromadex Corp | 11 | 1 | 1 | 0 | €2.64 | €5.58 | 111.205% |
Novavax Inc. | 8 | 1 | 6 | 0 | €14.09 | €27.38 | 94.271% |